URINARY HEMOPEXIN AS A MARKER OF LUPUS ACTIVITY AMONG EGYPTIAN SLE PATIENTS WITH PROLIFERATIVE LUPUS NEPHRITIS

被引：0
|
作者：
Sabry, Alaa [1 ]
Mahmoud, Rasha [1 ]
机构：
[1] Mansoura Nephrol & Dialysis Unit, Dept Nephrol, Mansoura, Egypt
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO142
引用
收藏
页码：I82 / I84
页数：3
相关论文
共 50 条
  • [41] Seasonal variation of lupus nephritis in a cohort of Egyptian patients
    Tarek Samy Abdelaziz
    Nehal K. Rakha
    Tarek Fayad
    Geilan A. Mahmoud
    Ahmed Fayed
    Hany Hammad
    Clinical Rheumatology, 2023, 42 : 1013 - 1018
  • [42] Anti-nucleosome antibodies as a marker of active proliferative lupus nephritis
    Bigler, C.
    Lopez-Trascasa, M.
    Potlukova, E.
    Moll, S.
    Danner, D.
    Schaller, M.
    Trendelenburg, M.
    SWISS MEDICAL WEEKLY, 2008, 138 : 53S - 53S
  • [43] Seasonal variation of lupus nephritis in a cohort of Egyptian patients
    Abdelaziz, Tarek Samy
    Rakha, Nehal K.
    Fayad, Tarek
    Mahmoud, Geilan A.
    Fayed, Ahmed
    Hammad, Hany
    CLINICAL RHEUMATOLOGY, 2023, 42 (04) : 1013 - 1018
  • [44] Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response
    Enghard, Philipp
    Rieder, Claudia
    Kopetschke, Katharina
    Klocke, J. R.
    Undeutsch, Reinmar
    Biesen, Robert
    Dragun, Duska
    Gollasch, Maik
    Schneider, Udo
    Aupperle, Karlfried
    Humrich, Jens Y.
    Hiepe, Falk
    Backhaus, Marina
    Radbruch, A. H.
    Burmester, Gerd R.
    Riemekasten, Gabriela
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 277 - 283
  • [45] Antiphospholipid antibodies in patients with proliferative and membranous lupus nephritis
    Ding, Xiaokai
    Chen, Chaosheng
    Zhang, Ji
    Lu, Guoyuan
    CLINICAL RHEUMATOLOGY, 2020, 39 (05) : 1531 - 1535
  • [46] Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
    Rovin, Brad H.
    Furie, Richard
    Latinis, Kevin
    Looney, R. John
    Fervenza, Fernando C.
    Sanchez-Guerrero, Jorge
    Maciuca, Romeo
    Zhang, David
    Garg, Jay P.
    Brunetta, Paul
    Appel, Gerald
    ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1215 - 1226
  • [47] Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis
    El Shahawy, Mohamed S.
    Hemida, Mahmoud H.
    Abdel-Hafez, Hafez A.
    El-Baz, Tarek Z.
    Lotfy, Abdel-Wahab M.
    Emran, Tarek M.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (04): : 264 - 268
  • [48] Urinary tweak is a marker for disease severity in human lupus nephritis
    Schwartz, N.
    Rovin, B.
    Gao, H.
    Lihe, S.
    Burkly, L. C.
    Michaelson, J. S.
    Putterman, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 464 - 465
  • [49] Antiphospholipid antibodies in patients with proliferative and membranous lupus nephritis
    Xiaokai Ding
    Chaosheng Chen
    Ji Zhang
    Guoyuan Lu
    Clinical Rheumatology, 2020, 39 : 1531 - 1535
  • [50] Urinary von Willebrand factor as a marker of lupus nephritis progression
    Bobkova, I
    Lysenko, L
    Polyantseva, L
    Tareyeva, I
    NEPHRON, 2001, 87 (04): : 369 - 370
12345